Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)
CNY 29.57
(11.21%)
CNY 29.57
(11.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.14 Billion CNY | 293.18% |
| 2022 | 545.44 Million CNY | 87.45% |
| 2021 | 290.98 Million CNY | 14.96% |
| 2020 | 253.1 Million CNY | 31.55% |
| 2019 | 192.4 Million CNY | -16.65% |
| 2018 | 230.83 Million CNY | 14.65% |
| 2017 | 201.33 Million CNY | -4.03% |
| 2016 | 209.78 Million CNY | 20.06% |
| 2015 | 174.73 Million CNY | 28.66% |
| 2014 | 135.8 Million CNY | -17.45% |
| 2013 | 164.52 Million CNY | 39.31% |
| 2012 | 118.1 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2.84 Billion CNY | 7.14% |
| 2024 Q2 | 2.65 Billion CNY | 6.98% |
| 2024 Q1 | 2.48 Billion CNY | 15.89% |
| 2023 Q2 | 778.27 Million CNY | 24.38% |
| 2023 FY | 2.14 Billion CNY | 293.18% |
| 2023 Q4 | 2.14 Billion CNY | 93.54% |
| 2023 Q3 | 1.1 Billion CNY | 42.38% |
| 2023 Q1 | 625.73 Million CNY | 14.72% |
| 2022 Q3 | 424.64 Million CNY | 1.42% |
| 2022 Q2 | 418.69 Million CNY | 43.27% |
| 2022 Q1 | 292.24 Million CNY | 0.43% |
| 2022 FY | 545.44 Million CNY | 87.45% |
| 2022 Q4 | 545.44 Million CNY | 28.45% |
| 2021 FY | 290.98 Million CNY | 14.96% |
| 2021 Q3 | 266.76 Million CNY | 0.74% |
| 2021 Q2 | 264.8 Million CNY | -8.46% |
| 2021 Q1 | 289.28 Million CNY | 14.3% |
| 2021 Q4 | 290.98 Million CNY | 9.08% |
| 2020 Q2 | 218.2 Million CNY | 42.35% |
| 2020 Q3 | 213.27 Million CNY | -2.26% |
| 2020 Q1 | 153.28 Million CNY | -20.33% |
| 2020 Q4 | 253.1 Million CNY | 18.68% |
| 2020 FY | 253.1 Million CNY | 31.55% |
| 2019 Q4 | 192.4 Million CNY | 0.0% |
| 2019 FY | 192.4 Million CNY | -16.65% |
| 2018 FY | 230.83 Million CNY | 14.65% |
| 2017 Q2 | 187.17 Million CNY | 0.0% |
| 2017 Q1 | 187.17 Million CNY | -10.78% |
| 2017 FY | 201.33 Million CNY | -4.03% |
| 2016 Q2 | 201.63 Million CNY | 0.0% |
| 2016 FY | 209.78 Million CNY | 20.06% |
| 2016 Q3 | 209.78 Million CNY | 4.04% |
| 2016 Q4 | 209.78 Million CNY | 0.0% |
| 2016 Q1 | 201.63 Million CNY | 15.39% |
| 2015 Q2 | 120.88 Million CNY | 0.0% |
| 2015 Q1 | 120.88 Million CNY | -10.99% |
| 2015 FY | 174.73 Million CNY | 28.66% |
| 2015 Q4 | 174.73 Million CNY | 0.0% |
| 2015 Q3 | 174.73 Million CNY | 44.54% |
| 2014 Q4 | 135.8 Million CNY | 0.0% |
| 2014 FY | 135.8 Million CNY | -17.45% |
| 2014 Q2 | 134.26 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 135.8 Million CNY | 1.15% |
| 2013 Q4 | 164.52 Million CNY | 13.49% |
| 2013 FY | 164.52 Million CNY | 39.31% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q3 | 144.96 Million CNY | 0.0% |
| 2012 FY | 118.1 Million CNY | 0.0% |